SEARCH
Natrium Capital Logo
menu
The independent chemicals Mergers & Acquisitions specialists
Our Services
Our Services
Natrium Capital offers direct, personal service from a close-knit and highly experienced team. Fee structures are approached in a flexible manner so as to accommodate the needs of all parties, and Natrium Capital’s role within a transaction can also always be tailored appropriately to circumstances.

Read More
Track Record
Track Record
Alasdair and the team share a wealth of experience in corporate finance and investment banking, having worked on over $100bn of completed deals over the last twenty years. These include highly significant Mergers & Acquisitions (M&A) transactions for PPG, Rohm & Haas, Rockwood, BASF, Shell, INEOS and Tata Chemicals.

Read More
Global Reach
Global Reach
Through carefully selected alliances, Natrium Capital is extending its international capabilities, bringing in specialised local experience and resources. We have established excellent alliances in Japan, India, Israel, South Korea, Turkey and the US, and other regions are in discussion

Read More
Chemicals, Materials
Natrium Capital has considerable expertise in cross-border transactions, essential to the global chemical and related industries. Our advisory team are scientists first, most having degrees in chemistry or closely related sciences, which results in a high level of specialist industry insight and an unparalleled appreciation of the factors affecting the chemicals, adhesives and materials sectors.
Read More
Paints, Inks, Coatings
With expertise developed by our leading professionals over the last thirty years, our knowledge and understanding of corporate finance in the paints, inks and coatings sectors is unrivalled. Our team has experience that spans several complete economic cycles and is respected for its understanding in both upturn and recessionary phases.
Read More
Cleantech, Biotech
Natrium Capital has a long track record of working with companies experiencing rapid change in their marketplace. As a boutique M&A specialist, we have the ability to respond quickly to evolving trends and to recognise the potential value of new technologies. Our scientific focus is central to retaining our position at the forefront of corporate finance in the biotech and cleantech sectors.
Read More
“… over $100bn of transactions over the last twenty years”